Gerhard Ehninger
Chief Executive Officer at Cellex Cell Professionals GmbH
Profile
Gerhard Ehninger is the founder of GEMoaB Monoclonals GmbH.
He currently holds the position of Co-Chief Executive Officer at Cellex Cell Professionals GmbH, Director at DKMS Americas, Director at AvenCell Therapeutics, Inc., Member-Supervisory Board at Universitätsklinikum Gießen und Marburg GmbH, and Trustee at Deutsche Stiftung Leben Spenden.
Previously, he served as Chairman at DKMS gemeinnützige GmbH and as a Member-Supervisory Board at Rhön-Klinikum AG.
Gerhard Ehninger active positions
Companies | Position | Start |
---|---|---|
DKMS Americas
DKMS Americas Miscellaneous Commercial ServicesCommercial Services DKMS Americas is a bone marrow donor center. The firm develops, organizes and operates bone marrow drives with the intention of saving the lives of patients. The company was founded in 2004 by Katharina Harf and is headquartered in New York, NY. | Director/Board Member | 2010-07-08 |
Universitätsklinikum Gießen und Marburg GmbH
Universitätsklinikum Gießen und Marburg GmbH Hospital/Nursing ManagementHealth Services Universitätsklinikum Gießen & Marburg GmbH operates as a university hospital. It provides health services to the citizens of nearby cities and opportunities for medical students to practice their professions. The hospital was founded in 2005 and is headquartered in Gießsen, Germany. | Director/Board Member | 2011-08-11 |
Deutsche Stiftung Leben Spenden | Director/Board Member | - |
Cellex Cell Professionals GmbH
Cellex Cell Professionals GmbH Miscellaneous Commercial ServicesCommercial Services Cellex Cell Professionals GmbH provides biological research and development for bone marrow and stem cell donations. The private company is based in Cologne, Germany. and has subsidiaries in Germany. The CEOs are Gerhard Ehninger, Carla Kreissig, Jochen Nething. The German company was founded in 2001. | Chief Executive Officer | - |
GEMoaB Monoclonals GmbH
GEMoaB Monoclonals GmbH Pharmaceuticals: MajorHealth Technology Part of AvenCell Therapeutics, Inc., GEMoaB Monoclonals GmbH is a German company that manufactures biopharmaceutical products. The private company is based in Dresden, Germany. The company was founded in 2014 by Gerhard Ehninger. GEMoaB Monoclonals was acquired by AvenCell Therapeutics, Inc. from Cellex Cell Professionals GmbH on March 30, 2022. | Founder | - |
AvenCell Therapeutics, Inc.
AvenCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AvenCell Therapeutics, Inc. is a biopharmaceutical company that develops immunotherapies to treat cancers. The private company is based in Cambridge, MA and has subsidiaries in Germany. Andrew D. Schiermeier has been the CEO of the company since 2021. | Director/Board Member | 2021-07-31 |
Former positions of Gerhard Ehninger
Companies | Position | End |
---|---|---|
DKMS gemeinnützige GmbH
DKMS gemeinnützige GmbH Miscellaneous Commercial ServicesCommercial Services DKMS gemeinnützige GmbH is a non-profit organization based in Tubingen, Germany. DKMS is dedicated to fighting various types of blood cancer through stem cell donations. The German company's mission is to inform people about the process of donating stem cells and encourage them to become part of the DKMS family. The non-profit company was founded in 2004 by Peter Harf, and the CEOs are Sirko Geist, Elke Neujahr, Alexander Schmidt. | Chairman | - |
RHÖN-KLINIKUM AG | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
RHÖN-KLINIKUM AG | Health Services |
Private companies | 7 |
---|---|
Universitätsklinikum Gießen und Marburg GmbH
Universitätsklinikum Gießen und Marburg GmbH Hospital/Nursing ManagementHealth Services Universitätsklinikum Gießen & Marburg GmbH operates as a university hospital. It provides health services to the citizens of nearby cities and opportunities for medical students to practice their professions. The hospital was founded in 2005 and is headquartered in Gießsen, Germany. | Health Services |
Deutsche Stiftung Leben Spenden | |
DKMS Americas
DKMS Americas Miscellaneous Commercial ServicesCommercial Services DKMS Americas is a bone marrow donor center. The firm develops, organizes and operates bone marrow drives with the intention of saving the lives of patients. The company was founded in 2004 by Katharina Harf and is headquartered in New York, NY. | Commercial Services |
DKMS gemeinnützige GmbH
DKMS gemeinnützige GmbH Miscellaneous Commercial ServicesCommercial Services DKMS gemeinnützige GmbH is a non-profit organization based in Tubingen, Germany. DKMS is dedicated to fighting various types of blood cancer through stem cell donations. The German company's mission is to inform people about the process of donating stem cells and encourage them to become part of the DKMS family. The non-profit company was founded in 2004 by Peter Harf, and the CEOs are Sirko Geist, Elke Neujahr, Alexander Schmidt. | Commercial Services |
Cellex Cell Professionals GmbH
Cellex Cell Professionals GmbH Miscellaneous Commercial ServicesCommercial Services Cellex Cell Professionals GmbH provides biological research and development for bone marrow and stem cell donations. The private company is based in Cologne, Germany. and has subsidiaries in Germany. The CEOs are Gerhard Ehninger, Carla Kreissig, Jochen Nething. The German company was founded in 2001. | Commercial Services |
GEMoaB Monoclonals GmbH
GEMoaB Monoclonals GmbH Pharmaceuticals: MajorHealth Technology Part of AvenCell Therapeutics, Inc., GEMoaB Monoclonals GmbH is a German company that manufactures biopharmaceutical products. The private company is based in Dresden, Germany. The company was founded in 2014 by Gerhard Ehninger. GEMoaB Monoclonals was acquired by AvenCell Therapeutics, Inc. from Cellex Cell Professionals GmbH on March 30, 2022. | Health Technology |
AvenCell Therapeutics, Inc.
AvenCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AvenCell Therapeutics, Inc. is a biopharmaceutical company that develops immunotherapies to treat cancers. The private company is based in Cambridge, MA and has subsidiaries in Germany. Andrew D. Schiermeier has been the CEO of the company since 2021. | Health Technology |
- Stock Market
- Insiders
- Gerhard Ehninger